August 4, 2021
Industry Group Respond to Proposals that Could Undermine Accelerated Approval
Read More
July 27, 2021
Australian Government Provides $3.3 Million to Support Rare Disease Patients
Read More
July 20, 2021
Netherland Fines Rare Disease Drugmaker for Excessive Price
Read More
June 8, 2021
Rare Disease Company Coalition Names Executive Committee
Read More
May 13, 2021
Rare Disease Drug Developers Form Coalition to Address Challenges
Read More
March 29, 2021
Report Finds Most Rare Disease Drugs Protected by Patents Rather than Exclusivity
Read More
March 8, 2021
NICE Recommends Novartis’ Gene Therapy for SMA
Read More
March 5, 2021
Rare Diseases Account for 11 percent of U.S. Drug Spending, Report Finds
Read More
March 4, 2021
Advocacy Groups Call on Governors to Prioritize Vaccination of Rare Disease Patients and Caregivers
Read More
February 25, 2021
When a Dollar Sign Becomes an Exclamation Point
Read More
January 28, 2021
Health Canada Seeks Input from Canadians on a National Strategy for High-Cost Drugs for Rare Diseases
Read More
January 28, 2021
NORD Issues State Report Cards on Policy Issues Critical to Rare Disease Patients
Read More
Load More
X